Regenerative Treatment Options

Different Regenerative Treatments Serve Different Purposes

The phrase “stem cell therapy” is often used so broadly that patients have no idea what they are actually receiving. Our responsibility is to make the options understandable.

Below is an overview of treatment categories that may be available. Availability and recommendations may change based on current law, product status, clinical judgment, and your individual case.

Platelet-Rich Plasma (PRP)

PRP is prepared from your own blood and concentrates platelets and their signaling proteins. It may be considered for certain joint, tendon, ligament, and soft-tissue concerns.

Questions to ask:

  • How is the PRP prepared?
  • What concentration or formulation is intended?
  • Why is PRP appropriate for this structure?
  • Will ultrasound guidance be used?

Bone Marrow-Derived Procedures

Bone marrow aspirate contains a mixture of cells and signaling components. It may be considered in selected musculoskeletal cases after evaluation.

Questions to ask:

  • Where will marrow be collected?
  • How will it be processed?
  • What is the treatment goal?
  • What evidence and alternatives apply to my condition?

Adipose-Derived Procedures

Adipose tissue contains a rich cellular and structural environment. Dr. Solt has extensive experience with same-day adipose-derived procedures. The exact processing method, intended use, and regulatory considerations must be discussed as part of informed consent.

Questions to ask:

  • What tissue will be collected and how?
  • What processing occurs?
  • What regulatory framework or exception is being relied upon?
  • What exactly will be administered and where?

Donor-Derived Birth-Tissue Products

Products sourced from umbilical cord, Wharton’s jelly, amniotic tissue, or related birth tissues vary significantly. They should not automatically be described as living stem-cell products. We discuss the specific product category, source, testing, intended use, limitations, and regulatory status when such a product is being considered.

Questions to ask:

  • Does the product contain viable cells?
  • What is the manufacturer and lot information?
  • What donor screening and sterility testing are performed?
  • Is this use FDA-approved or otherwise authorized?

Other Regenerative Options

Depending on the case, the plan may include non-cellular biologics, supportive injections, IV therapies, rehabilitation guidance, or referral for a different form of care.

Questions to ask:

  • What is the specific treatment?
  • What is the intended benefit?
  • What are the risks and alternatives?
  • How does it fit the overall plan?

 

No treatment category is automatically “best.” The best option is the one that is medically reasonable, transparently explained, technically well executed, and aligned with your goals.